15 lead form fill jobs found in Remote

Refine Search
Current Search
Business Development Remote lead form fill
Refine by Categories
Refine by Job Type
Aug 17, 2026
Full time
Apheresis Ops Account Manager
Dendreon Remote (KS)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Apheresis Ops Account Manager
Dendreon Remote (AR)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Apheresis Ops Account Manager
Dendreon Remote (NE)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Medical Science Liaison - Central
Dendreon Remote (United States)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Key Account Manager - Upstate New York
Dendreon Remote (New York, NY)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Apheresis Ops Account Manager
Dendreon Remote (MN)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Apheresis Ops Account Manager
Dendreon Remote (WI)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Apheresis Ops Account Manager
Dendreon Remote (MI)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Apheresis Ops Account Manager
Dendreon Remote (IA)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Apheresis Ops Account Manager
Dendreon Remote (OH)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Apheresis Ops Account Manager
Dendreon Remote (KY)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Apheresis Ops Account Manager
Dendreon Remote (IL)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Apheresis Ops Account Manager
Dendreon Remote (IN)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Apheresis Ops Account Manager
Dendreon Remote (MO)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.
Aug 17, 2026
Full time
Apheresis Ops Account Manager
Dendreon Remote (OK)
Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.